Overexpression of Sema 3 E and Sema 5 A in pilocytic astrocytoma

We have previously found that Sema5A, a member of the semaphorin gene family, is up-regulated in pediatric pilocytic astrocytomas (PA) at the mRNA level by microarray analysis and real-time RT-PCR. By further analysis of the expression level of all 17 semaphorin genes in the microarray dataset, we found that Sema5A and Sema3E are the only two semaphorin genes that are highly up-regulated in pilocytic astrocytomas. In this study, the up-regulation of Sema3E was further confirmed by real-time RT-PCR. Furthermore, the over-expression of both SEMA3E and SEMA5A proteins were also confirmed by Western blot analysis and immunohistochemistry. since pilocytic astrocytoma is characterized by extensive vasculature, co-immunofluorescent staining of both CD31 and SEMA3E (or SEMA5A) was performed. The result showed that a higher expression of seMA3e was around the CD31 positive endothelial cells. Based on semaphorin’s function in angiogenesis and a higher expression of seMA3e and seMA5A around endothelial cells in these PA samples, these genes could be potential biological markers and anti-angiogenesis therapeutic targets for pilocytic astrocytomas.

[1]  I. Pollack,et al.  A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A Pediatric Brain Tumor Consortium (PBTC) study. , 2017 .

[2]  Q. Mo,et al.  Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival , 2016, Oncotarget.

[3]  S. Offermanns,et al.  Semaphorins and plexins as therapeutic targets , 2014, Nature Reviews Drug Discovery.

[4]  R. McLendon,et al.  Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study. , 2014, Neuro-oncology.

[5]  I. Treilleux,et al.  Semaphorin 3E suppresses tumor cell death triggered by the plexin D1 dependence receptor in metastatic breast cancers. , 2013, Cancer cell.

[6]  Roland Eils,et al.  Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma , 2013, Nature Genetics.

[7]  Heather L. Mulder,et al.  Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas , 2013, Nature Genetics.

[8]  Christopher A. Miller,et al.  Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma , 2013, Genome research.

[9]  S. Batra,et al.  Secreted semaphorin 5A suppressed pancreatic tumour burden but increased metastasis and endothelial cell proliferation , 2012, British Journal of Cancer.

[10]  Andrea Bertotti,et al.  Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice. , 2010, The Journal of clinical investigation.

[11]  E. Hoving,et al.  Tumour vasculature and angiogenic profile of paediatric pilocytic astrocytoma; is it much different from glioblastoma? , 2010, Neuropathology and applied neurobiology.

[12]  M. Repka,et al.  Outcome analysis of childhood low‐grade astrocytomas , 2008, Pediatric blood & cancer.

[13]  Albert Becker,et al.  Frequent recurrence and progression in pilocytic astrocytoma in adults , 2007, Cancer.

[14]  Thomas M. Jessell,et al.  Gating of Sema3E/PlexinD1 Signaling by Neuropilin-1 Switches Axonal Repulsion to Attraction during Brain Development , 2007, Neuron.

[15]  B. Scheithauer,et al.  The 2007 WHO Classification of Tumours of the Central Nervous System , 2007, Acta Neuropathologica.

[16]  B. Birlik,et al.  Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas , 2006, Neuropathology and applied neurobiology.

[17]  P. Paquier,et al.  Functional outcome after low‐grade astrocytoma treatment in childhood , 2006, Cancer.

[18]  Z. Bao,et al.  Sema3D, Sema3F, and Sema5A are expressed in overlapping and distinct patterns in chick embryonic heart , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[19]  S. Guirado,et al.  Semaphorin5A expression in the developing chick telencephalon , 2005, Brain Research Bulletin.

[20]  Giorgio F. Gilestro,et al.  Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis. , 2005, Cancer research.

[21]  P. Kleihues,et al.  Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. , 2005, Journal of neuropathology and experimental neurology.

[22]  A. Moorman,et al.  Inactivation of the Sema5a Gene Results in Embryonic Lethality and Defective Remodeling of the Cranial Vascular System , 2005, Molecular and Cellular Biology.

[23]  Thomas M. Jessell,et al.  Semaphorin 3E and Plexin-D1 Control Vascular Pattern Independently of Neuropilins , 2005, Science.

[24]  K. Wong,et al.  Expression analysis of juvenile pilocytic astrocytomas by oligonucleotide microarray reveals two potential subgroups. , 2005, Cancer research.

[25]  Michael J. Hansen,et al.  Semaphorin 5A Is a Bifunctional Axon Guidance Cue Regulated by Heparan and Chondroitin Sulfate Proteoglycans , 2004, Neuron.

[26]  Giorgio F. Gilestro,et al.  Plexin‐B3 is a functional receptor for semaphorin 5A , 2004, EMBO reports.

[27]  S. Baruchel,et al.  Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood. , 2003, Medical and pediatric oncology.

[28]  D. Figarella-Branger,et al.  Pilocytic Astrocytomas in Children: Prognostic Factors—A Retrospective Study of 80 Cases , 2003, Neurosurgery.

[29]  M. Tessier-Lavigne,et al.  Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function , 2003, Nature.

[30]  M. Weller,et al.  Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins , 2003, Glia.

[31]  D. Sretavan,et al.  Invariant Sema5A inhibition serves an ensheathing function during optic nerve development , 2003, Development.

[32]  K. Skullerud,et al.  Long-Term Outcome after Resection of Benign Cerebellar Astrocytomas in Children and Young Adults (0–19 Years): Report of 110 Consecutive Cases , 2002, Pediatric Neurosurgery.

[33]  R. Zimmerman,et al.  Postoperative surveillance imaging in children with cerebellar astrocytomas. , 1996, Journal of neurosurgery.

[34]  C. Giannini,et al.  Pilocytic astrocytoma: pathology, molecular mechanisms and markers. , 2015, Acta neuropathologica.

[35]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .